207_Combined course Presentations

Elderly patients: TMZ vs RT (NORDIC and NOA-08)

60 Gy

Malmstrom A. et al. Lancet Oncol 2012;13

 TMZ alone is not inferior to RT alone in the treatment of Elderly GBM.

Wick W. et al. Lancet Oncol 2012;13

 MGMT promoter methylation seems to be a useful biomarker and could aid decision-making